LifeArc Revenue and Competitors

UK

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • LifeArc's estimated annual revenue is currently $50.2M per year.(i)
  • LifeArc's estimated revenue per employee is $127,500

Employee Data

  • LifeArc has 394 Employees.(i)
  • LifeArc grew their employee count by 27% last year.

LifeArc's People

NameTitleEmail/Phone
1
Executive Assistant to Chief Financial Officer & Interim CEOReveal Email/Phone
2
Chief Communications OfficerReveal Email/Phone
3
Interim Chief People OfficerReveal Email/Phone
4
Head IT DeliveryReveal Email/Phone
5
Head EventsReveal Email/Phone
6
Head BrandReveal Email/Phone
7
Head Digital MarketingReveal Email/Phone
8
Head ContentReveal Email/Phone
9
Head Therapeutic PlatformsReveal Email/Phone
10
Head Media & Public RelationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.1M69-13%$16.5MN/A
#2
$264.2M1850-1%N/AN/A
#3
$51.9M401-10%$12.6MN/A
#4
$22.5M205-39%$63.8MN/A
#5
$1.1M21-19%$781.7KN/A
#6
$21.3M19033%N/AN/A
#7
$11.9M11710%N/AN/A
#8
$3.8M46-10%N/AN/A
#9
$8.8M86-16%N/AN/A
#10
$2.5M31-40%N/AN/A
Add Company

What Is LifeArc?

LifeArc® is a medical research charity that pioneers new ways to turn great science into greater patient impact. We have a 25 year legacy of helping scientists and organisations advance their research into therapeutics and diagnostics for patients, including Keytruda®(cancer), Actemra® (rheumatoid arthritis), Tysabri® (multiple sclerosis) and Entyvio® (Crohn’s disease) and a test for antimicrobial resistance. Find out more about how we fund, protect and develop much needed research at Lifearc.org or Twitter @lifearc1

keywords:N/A

N/A

Total Funding

394

Number of Employees

$50.2M

Revenue (est)

27%

Employee Growth %

N/A

Valuation

N/A

Accelerator

LifeArc News

2022-04-20 - CNN's 'Mission: Ahead' meets the pioneers pushing the ...

Hundreds of organizations have adopted the company's tools, Nanome says, including LifeArc, a UK-based medical research charity.

2022-04-20 - AviadoBio’s Gene Therapy Candidate Receives Orphan Designation from Food and Drug Administration and European Commission in Frontotemporal Dementia

... EQT Lifesciences, Dementia Discovery Fund (DDF), F-Prime Capital, Johnson & Johnson Innovation – JJDC, Inc. (JJDC), and LifeArc.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$50.2M394-5%N/A
#2
$88.7M3946%N/A
#3
$159.1M3948%N/A
#4
$99.5M39422%N/A
#5
$69M394N/AN/A